| Business Summary | | Sigma-Aldrich
Corporation
develops,
manufactures
and
distributes
a
broad
range
of
biochemicals,
organic
chemicals,
chromatography
products
and
diagnostic
reagents.
These
chemical
products
and
kits
are
used
in
scientific
and
genomic
research,
biotechnology,
pharmaceutical
development,
the
chemical
industry
and
for
the
diagnosis
of
disease.
The
Company
operates
in
33
countries,
lists
more
than
85,000
chemical
products
and
distributes
these
products
in
over
160
countries.
Sigma-Aldrich's
life
science
products
are
used
in
many
applications
and
disciplines
including
molecular
biology,
cell
biology,
cell
culture,
protein
analysis
and
chromatography,
DNA
sequencing
and
gene
studies. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Sigma-Aldrich
develops,
manufactures
and
distributes
a
broad
range
of
biochemicals,
organic
chemicals,
diagnostic
reagents
and
chromatography
products.
For
the
six
months
ended
6/30/01,
revenues
rose
6%
to
$599.4
million.
Earnings
from
continuing
operations
fell
7%
to
$73.7
million.
Revenues
reflect
higher
fine
chemical
laboratory
products
and
science
products
sales.
Earnings
were
offset
by
higher
S/G/A
costs
as
a
percentage
of
sales
due
to
marketing
initatives. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| David Harvey, 61 Chairman,
Pres, CEO | $654K | Michael Hogan, 48 CFO,
Chief Admin. Officer, Sec. | 373K | Larry Blazevich, 53 VP,
CIO | 274K | Terry Colvin, 45 VP
of HR | -- | Rodney Kelley, 46 VP,
Safety and Compliance | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|